Isbn: 9781402072321 - biomedical aspects of drug targeting (12 résultats)

Affiner la recherche

  • Livres (12)

à

Fourchette de prix personnalisée (EUR)

à

    • Langue : anglais

      Edité par Kluwer, USA, 2002

      1402072325 / 9781402072321

      • Couverture rigide

      Vendeur : The Book Exchange, Macclesfield, CHESH, Royaume-UniThe Book Exchange

      Vendeur avec une évaluation de 4 étoiles
      Contacter le vendeur

      Etat: Occasion - Bon

      EUR 21,50

      EUR 23,27 expédition 
      Expédition depuis Royaume-Uni vers Etats-Unis

      Quantité disponible : 1 disponible(s)

      Hardcover. Etat : Near Fine. 1402072325. Hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 506 pages, index, illustrated with charts, tables and diagrams. Includes general principles of drug targeting, targeting in the cardiovascular system, tumor targeting, brain targeting, miscellaneous targeting and novel approaches. In a course-like fashion: from general and simple to specific and complex material. For pharmacologists and drug discovery researchers, along with advanced level graduate students. The book focuses on ligand-mediated drug targeting strategies, with additional chapters on general aspects of drug delivery that are of paramount importance in drug targeting (biological barriers, stealth technologies). Included are topics on targeting of genetic materials important in the biomedical context of the ligand-mediated targeting. Contents as new, clean, tight and bright. Book.

    • Langue : anglais

      Edité par Springer, 2003

      1402072325 / 9781402072321

      • Couverture rigide

      Vendeur : Ria Christie Collections, Uxbridge, Royaume-UniRia Christie Collections

      Vendeur avec une évaluation de 5 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 165,21

      EUR 13,14 expédition 
      Expédition depuis Royaume-Uni vers Etats-Unis

      Quantité disponible : Plus de 20 disponibles

      Etat : New. In.

    • Langue : anglais

      Edité par Kluwer Academic Publishers, 2002

      1402072325 / 9781402072321

      • Couverture rigide

      Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandeKennys Bookshop and Art Galleries Ltd.

      Vendeur avec une évaluation de 5 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 205,57

      EUR 9,50 expédition 
      Expédition depuis Irlande vers Etats-Unis

      Quantité disponible : 15 disponible(s)

      Etat : New. Includes general principles of drug targeting, targeting in the cardiovascular system, tumor targeting, brain targeting, miscellaneous targeting and novel approaches for targeting. This book focuses on ligand-mediated drug targeting strategies, with chapters on general aspects of drug delivery that are of importance in drug targeting. Editor(s): Muzykantov, Vladimir R.; Torchilin, Vladimir P. Num Pages: 506 pages, biography. BIC Classification: MMG; MQW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 234 x 156 x 28. Weight in Grams: 917. . 2002. Hardback. . . . .

    • Langue : anglais

      Edité par Springer, 2003

      1402072325 / 9781402072321

      • Couverture rigide

      Vendeur : Books Puddle, New York, NY, Etats-UnisBooks Puddle

      Vendeur avec une évaluation de 4 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 240,10

      EUR 3,44 expédition 
      Expédition nationale : Etats-Unis

      Quantité disponible : 4 disponible(s)

      Etat : New. pp. 532.

    • Langue : anglais

      Edité par Kluwer Academic Publishers, 2003

      1402072325 / 9781402072321

      • Couverture rigide

      Vendeur : Kennys Bookstore, Olney, MD, Etats-UnisKennys Bookstore

      Vendeur avec une évaluation de 5 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 256,36

      EUR 9,04 expédition 
      Expédition nationale : Etats-Unis

      Quantité disponible : 15 disponible(s)

      Etat : New. Includes general principles of drug targeting, targeting in the cardiovascular system, tumor targeting, brain targeting, miscellaneous targeting and novel approaches for targeting. This book focuses on ligand-mediated drug targeting strategies, with chapters on general aspects of drug delivery that are of importance in drug targeting. Editor(s): Muzykantov, Vladimir R.; Torchilin, Vladimir P. Num Pages: 506 pages, biography. BIC Classification: MMG; MQW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 234 x 156 x 28. Weight in Grams: 917. . 2002. Hardback. . . . . Books ship from the US and Ireland.

    • Langue : anglais

      Edité par Springer US, 2003

      1402072325 / 9781402072321

      • Couverture rigide
      • impression à la demande

      Vendeur : moluna, Greven, Allemagnemoluna

      Vendeur avec une évaluation de 5 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 136,16

      EUR 48,99 expédition 
      Expédition depuis Allemagne vers Etats-Unis

      Quantité disponible : Plus de 20 disponibles

      Gebunden. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic an.

    • Autres images

      Langue : anglais

      Edité par Springer US, 2003

      1402072325 / 9781402072321

      • Couverture rigide
      • impression à la demande

      Vendeur : preigu, Osnabrück, Allemagnepreigu

      Vendeur avec une évaluation de 5 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 141,20

      EUR 70,00 expédition 
      Expédition depuis Allemagne vers Etats-Unis

      Quantité disponible : 5 disponible(s)

      Buch. Etat : Neu. Biomedical Aspects of Drug Targeting | Vladimir P. Torchilin (u. a.) | Buch | xvii | Englisch | 2003 | Springer US | EAN 9781402072321 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.

    • Langue : anglais

      Edité par Springer US, Springer New York Feb 2003, 2003

      1402072325 / 9781402072321

      • Couverture rigide
      • impression à la demande

      Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagnebuchversandmimpf2000

      Vendeur avec une évaluation de 5 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 160,49

      EUR 60,00 expédition 
      Expédition depuis Allemagne vers Etats-Unis

      Quantité disponible : 1 disponible(s)

      Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic anticancer drugs or specific agents, such as enzymes and genetic materials, since their effective and safe action requires precise cellular or even sub-cellular addressing in the target organ. To meet safety, efficiency and specificity requirements, drugs somehow must be targeted to the sites of their expected therapeutic action. The idea of the 'magic bullet,' or drug targeting, proposed by Erlich a century ago, generates great and continuously growing interest in biomedical, industrial and financial circles. This book is focused on the strategies designed to target therapeutic or diagnostic agents to the disease sites. In an attempt to include in this volume the set of chapters reflecting both traditional and emerging areas of drug targeting, we have contacted many leading scientists in the field asking for their contributions. Their responses were most favorable and encouraging. As a result, we have succeeded in assembling a series of outstanding contributions reflecting practically all the key areas of drug targeting. The final structure of this book is as follows.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 532 pp. Englisch.

    • Langue : anglais

      Edité par Springer US Feb 2003, 2003

      1402072325 / 9781402072321

      • Couverture rigide
      • impression à la demande

      Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AllemagneBuchWeltWeit Ludwig Meier e.K.

      Vendeur avec une évaluation de 5 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 213,99

      EUR 23,00 expédition 
      Expédition depuis Allemagne vers Etats-Unis

      Quantité disponible : 2 disponible(s)

      Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic anticancer drugs or specific agents, such as enzymes and genetic materials, since their effective and safe action requires precise cellular or even sub-cellular addressing in the target organ. To meet safety, efficiency and specificity requirements, drugs somehow must be targeted to the sites of their expected therapeutic action. The idea of the 'magic bullet,' or drug targeting, proposed by Erlich a century ago, generates great and continuously growing interest in biomedical, industrial and financial circles. This book is focused on the strategies designed to target therapeutic or diagnostic agents to the disease sites. In an attempt to include in this volume the set of chapters reflecting both traditional and emerging areas of drug targeting, we have contacted many leading scientists in the field asking for their contributions. Their responses were most favorable and encouraging. As a result, we have succeeded in assembling a series of outstanding contributions reflecting practically all the key areas of drug targeting. The final structure of this book is as follows. 532 pp. Englisch.

    • Langue : anglais

      Edité par Springer, 2003

      1402072325 / 9781402072321

      • Couverture rigide
      • impression à la demande

      Vendeur : Majestic Books, Hounslow, Royaume-UniMajestic Books

      Vendeur avec une évaluation de 4 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 248,08

      EUR 7,56 expédition 
      Expédition depuis Royaume-Uni vers Etats-Unis

      Quantité disponible : 4 disponible(s)

      Etat : New. Print on Demand pp. 532 Illus.

    • Langue : anglais

      Edité par Springer, 2003

      1402072325 / 9781402072321

      • Couverture rigide
      • impression à la demande

      Vendeur : Biblios, frankfurt am main, HESSE, AllemagneBiblios

      Vendeur avec une évaluation de 4 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 255,61

      EUR 9,95 expédition 
      Expédition depuis Allemagne vers Etats-Unis

      Quantité disponible : 4 disponible(s)

      Etat : New. PRINT ON DEMAND pp. 532.

    • Langue : anglais

      Edité par Humana, 2003

      1402072325 / 9781402072321

      • Couverture rigide
      • impression à la demande

      Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

      Vendeur avec une évaluation de 5 étoiles
      Contacter le vendeur

      Etat: Neuf

      EUR 341,96

      EUR 30,50 expédition 
      Expédition depuis Allemagne vers Etats-Unis

      Quantité disponible : 1 disponible(s)

      Buch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic anticancer drugs or specific agents, such as enzymes and genetic materials, since their effective and safe action requires precise cellular or even sub-cellular addressing in the target organ. To meet safety, efficiency and specificity requirements, drugs somehow must be targeted to the sites of their expected therapeutic action. The idea of the 'magic bullet,' or drug targeting, proposed by Erlich a century ago, generates great and continuously growing interest in biomedical, industrial and financial circles. This book is focused on the strategies designed to target therapeutic or diagnostic agents to the disease sites. In an attempt to include in this volume the set of chapters reflecting both traditional and emerging areas of drug targeting, we have contacted many leading scientists in the field asking for their contributions. Their responses were most favorable and encouraging. As a result, we have succeeded in assembling a series of outstanding contributions reflecting practically all the key areas of drug targeting. The final structure of this book is as follows.